Abstract
Aberrantly activated macrophages, which overproduce inflammatory mediators, are involved in the pathogenesis of many inflammatory diseases. We analyzed the anti-inflammatory activity of lansoprazole (LPZ), a typical proton pump (P-ATPase) inhibitor, on RAW264.7 murine macrophages. Treatment of lipopolysaccharide (LPS)-stimulated RAW264.7 cells with LPZ inhibited the production of nitric oxide (NO) and prostaglandin E2 (PGE2). Since P-ATPase expression was not observed in RAW264.7 cells, the anti-inflammatory effect of LPZ was independent of ATPase. In contrast, diphenylene iodonium (DPI), an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, decreased NO but not PGE2 levels. LPZ suppressed the LPS-stimulated production by RAW264.7 cells of reactive oxygen species (ROS), which plays an important role in inflammatory responses. ROS elevation in these cells was associated with NO but not PGE2 production, suggesting that LPZ inhibits NO production by suppressing NADPH oxidase activity. These findings suggest that LPZ may be useful in the treatment of many inflammatory diseases associated with activated macrophages.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Biswas, K., U. Bandyopadhyay, I. Chattopadhyay, A. Varadaraj, E. Ali, and R.K. Banerjee. 2003. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. Journal of Biological Chemistry 278(13): 10993–11001.
Yoshida, N., T. Yoshikawa, Y. Tanaka, N. Fujita, K. Kassai, Y. Naito, and M. Kondo. 2000. A new mechanism for anti-inflammatory actions of proton pump inhibitors—inhibitory effects on neutrophil–endothelial cell interactions. Alimentary Pharmacology & Therapeutics 14(Suppl 1): 74–81.
Dickinson, J.B. 1994. Is omeprazole helpful in inflammatory bowel disease? Journal of Clinical Gastroenterology 18(4): 317–319.
Elliott, M.J., R.N. Maini, M. Feldmann, A. Long-Fox, P. Charles, H. Bijl, and J.N. Woody. 1994. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344(8930): 1125–1127.
Ikeda, U., and K. Shimada. 1999. Statins and monocytes. Lancet 353(9169): 2070.
Kim, J.K., S.M. Oh, H.S. Kwon, Y.S. Oh, S.S. Lim, and H.K. Shin. 2006. Anti-inflammatory effect of roasted licorice extracts on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biochemical and Biophysical Research Communications 345(3): 1215–1223.
Sakao, K., K.A. Takahashi, O. Mazda, Y. Arai, H. Tonomura, A. Inoue, M. Saito, M. Fujioka, H. Takamiya, J. Imanishi, and T. Kubo. 2008. Enhanced expression of interleukin-6, matrix metalloproteinase-13, and receptor activator of NF-kappaB ligand in cells derived from osteoarthritic subchondral bone. Journal of Orthopaedic Science 13(3): 202–210.
Li, J.M., N.P. Gall, D.J. Grieve, M. Chen, and A.M. Shah. 2002. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 40(4): 477–484.
Blandizzi, C., G. Natale, G. Gherardi, G. Lazzeri, C. Marveggio, R. Colucci, D. Carignani, and M. Del Tacca. 1999. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Digestive Diseases and Sciences 44(10): 2039–2050.
Nakamura, M., M. Asada, K. Atsuda, H. Matsui, T. Watanabe, K. Higuchi, T. Arakawa, N. Hibi, and K. Tsuchimoto. 2005. Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis. Inflammopharmacology 13(1–3): 303–315.
Hinoki, A., K. Yoshimura, K. Fujita, M. Akita, R. Ikeda, M. Nagashima, M. Nomura, and A. Satomi. 2006. Suppression of proinflammatory cytokine production in macrophages by lansoprazole. Pediatric Surgery International 22(11): 915–923.
Harris, S.G., J. Padilla, L. Koumas, D. Ray, and R.P. Phipps. 2002. Prostaglandins as modulators of immunity. Trends in Immunology 23(3): 144–150.
Lee, T.Y., K.C. Lee, S.Y. Chen, and H.H. Chang. 2009. 6-Gingerol inhibits ROS and iNOS through the suppression of PKC-alpha and NF-kappaB pathways in lipopolysaccharide-stimulated mouse macrophages. Biochemical and Biophysical Research Communications 382(1): 134–139.
Adams, D.O., and T.A. Hamilton. 1984. The cell biology of macrophage activation. Annual Review of Immunology 2: 283–318.
Sarna, L.K., N. Wu, S.Y. Hwang, Y.L. Siow, and O. Karmin. 2010. Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages. Canadian Journal of Physiology and Pharmacology 88(3): 369–378.
Sadowska, A.M., B. Manuel-Y-Keenoy, and W.A. De Backer. 2007. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulmonary Pharmacology and Therapeutics 20(1): 9–22.
Acknowledgments
This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education Culture, Sports, Science, and Technology of Japan to R.S.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakagawa, S., Arai, Y., Kishida, T. et al. Lansoprazole Inhibits Nitric Oxide and Prostaglandin E2 Production in Murine Macrophage RAW 264.7 Cells. Inflammation 35, 1062–1068 (2012). https://doi.org/10.1007/s10753-011-9412-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-011-9412-7